Everything You Need to Know About Insulin Pens

Insulin Pens for Diabetes: A Complete Scientific Guide

Insulin Pens for Diabetes: A Complete Scientific Guide
Getty Images

For people who require insulin therapy, staying on top of multiple daily injections and getting the dosages right can be an overwhelming task. Insulin pens can make diabetes management easier, more accurate, and less painful, and they are getting easier to use and smarter by the day.

How Insulin Injection Methods Compare

Insulin injections are taken by people with diabetes whose bodies don’t make insulin, don’t make enough of it, or don’t respond effectively to the insulin they are making. The injections are typically self-administered, up to several times a day, using a needle, syringe, and vial; a pen; or a computerized pump. Inhalers and jet injectors can also deliver insulin, though these aren’t as common.

On average, someone with insulin-dependent diabetes spends $4,800 annually on medications and other supplies to manage their diabetes.

 Medicare Part D, along with numerous states, caps the cost of insulin at $35 per month. Still, about 40 percent of adults in the United States pay more than $150 each month just for their insulin.

For many people, the least-expensive way to take insulin is using a needle, syringe, and vial, because these supplies are most likely to be covered under Medicare, state Medicaid plans, and private insurance versus other injection methods.

 But syringe delivery is also the most painful and difficult method, with a higher risk of dosing errors and hypoglycemia (low blood sugar) episodes than other methods.
People who use pumps receive insulin 24 hours a day in a manner that mimics the body’s own way of releasing insulin. Yet pump delivery can be expensive — costing as much as $6,500 for the device without insurance, and devices typically last only two to three years. Pumps have an additional cost of $2,000 to $3,000 per year in supplies.

With insulin pens, a cartridge of insulin, which may come filled or need to be inserted, is contained within the pen. The user dials the dosage on the pen, and then the pen injects insulin beneath the skin through a needle. To get the full dose, the pen needle should be “primed” with each use to remove air bubbles by following the manufacturer's directions. The knob of the pen must be pushed all the way in and held at the injection site for 6 to 10 seconds before the needle is pulled out. (Cleveland Clinic provides detailed instructions on how to inject yourself properly with a pen.)

According to GoodRx, the recent availability of generic insulin pens drastically reduced the cost, dropping the price from about $380 for a package of five Humalog 75/25 KwikPen pens containing 300 units of insulin to about $260 for a comparable five-pack of generic insulin lispro 75/25 KwikPens. In general, pen users tend to spend more than syringe users, but that can be in part because they are more likely to use pricier analogue (synthetic) insulins and to inject more units of insulin per day.

The Benefits of Using an Insulin Pen to Manage Diabetes

“Insulin pens can make administering insulin tremendously easy for a variety of reasons,” says Andrew S. Bzowyckyj, PharmD, CDCES, a pharmacist and the scientific director for the National Kidney Foundation’s kidney learning solutions team, who is based in Hillsboro, Oregon.

“First, there is no need for complex maneuvering to draw the insulin out of a vial. In addition, the final dose to be administered is a lot easier to see with a pen because of the relatively large numbers in the dosing window, rather than counting tick marks on a syringe. Lastly, many of the newer insulin formulations are now available in unique concentrations that are unsafe to administer with a traditional syringe because of the need for additional calculations to administer the correct dose. Not everyone prefers to use an insulin pen, but those who do find it easier and much more convenient to use than the traditional vial and syringe,” Bzowyckyj says. People who inject insulin also generally find pens to be less painful, more convenient, and easier to use than syringes.

The American Diabetes Association recommends insulin pens for most people who need multiple daily injections in its current standards of care. In comparison to syringes, pens are better for users who have dexterity or vision limitations, and they make it easier for caregivers to deliver doses accurately, according to the guidelines.

Despite the higher costs upfront, pen injections may save people more money than syringes. According to a study by Doctors Without Borders, when you take into account the cost of both the insulin and the injection device, pens may be the more affordable option. After surveying 400 people on insulin, the study reports that 82 percent preferred using pens over syringes because they were less painful, more accurate, and less embarrassing to use in public.

How Pens Work to Store and Administer Insulin

Pens can contain 300 to 900 units of insulin, depending on the device and the insulin concentration. The standard concentration is 100 units per milliliter (mL) of insulin, known as U-100, though higher concentrations exist, such as U-200, U-300, and U-500.

 Typically, a pen will hold 3 mL of insulin.
Pens deliver insulin through needles that range in length from 4 to 12.7 millimeters, and in thickness (gauge) from 22 (thicker) to 34 (thinner). A thicker needle is capable of giving a dose of insulin more rapidly, while a thinner needle is less painful to use.

 Most people prefer using a 4-mm-long needle because it tends to be easier to inject in the correct spot and is less painful.

Types of Insulin Pens

They come in three distinct formats.

Disposable Insulin Pens

These come with filled insulin cartridges. The entire pen is discarded after all the insulin has been used. Some examples of disposable insulin pens and their price estimates per GoodRx include:

  • A Novolog FlexPen containing 300 units of fast-acting (mealtime) insulin aspart has a retail price of $145.87 per pen ($0.49 per unit) and a discount price of $41.12 ($.014 per unit).
  • A Toujeo Max SoloStar containing 900 units of long-acting insulin glargine, taken once a day, costs $347.01 per pen retail ($0.38 per unit) and $268.83 with a discount ($0.30 per unit).

Reusable Insulin Pens

These come with replaceable cartridges and are meant to last years. Most reusable pens currently available are now smart pens.

Smart or Connected Insulin Pens

Generally, reusable pens are able to record and transmit data wirelessly, and are often used alongside a mobile app or a continuous glucose monitor (CGM). Functions vary by pen, but the most integrated smart pens log glucose level, carbohydrate intake, and the number of insulin doses administered, says Bzowyckyj.

“Many of these insulin pens sync with an app via Bluetooth technology to help log a lot of these important elements of a person’s care plan,” says Bzowyckyj. “Many times I hear patients say they may not remember if they administered their insulin dose before a meal for a variety of reasons, which then stresses them out because they do not want to double dose and risk hypoglycemia. Not only can insulin pen technology help document doses administered but it can also help patients determine the best dose to administer by factoring in variables such as anticipated carbohydrate intake, active insulin time, and current and goal glucose levels.”

The apps may also track additional health data, such as patient weight and steps or physical activity, either by syncing with a fitness tracker or when the user manually logs the data, Bzowyckyj adds.

“My patients love smart pens,” says Diana Isaacs, PharmD, CDCES, a clinical pharmacy specialist and the director of education and training in diabetes technology at Cleveland Clinic's Endocrinology and Metabolism Institute in Ohio. “For any patient of mine who takes mealtime insulin and prefers not to use an insulin pump, this is a great option and one that I encourage.” (Note that Isaacs receives compensation as a speaker for Medtronic, Dexcom, and Abbott Diabetes.)

Tips for Using Insulin Pens Safely

Insulin pens that are in use can be refrigerated or kept at room temperature (below 86 degrees F). Discard them after the manufacturer-listed number of days has elapsed. This typically ranges between 14 and 42 days, but check the instructions to be certain.

You can keep unused pens in the refrigerator at 36 to 46 degrees F, then warm them to room temperature when you are ready to use them. Once they are outside the fridge, the expiration date no longer applies.

Keep in mind that cartridges and filled pens contain only one type of insulin. Two separate injections must be given with different insulin pens if you use two types of insulin. And you should never share an insulin pen.

 Also, never use a syringe to withdraw insulin from a pen or cartridge, which can lead to dosing errors when the pen is used again.

Recent Developments in Insulin Pen Technology

We asked Bzowyckyj, Isaacs, and Joshua D. Miller, MD, a clinical associate professor of medicine for Stony Brook Medicine in Hauppauge, New York, about the latest developments in insulin pen technology, which include:

  • Disposable pens in concentrations of 200 units per mL and 300 units per mL
  • The ability to administer partial units for more highly customized doses
  • Memory or smart functions that allow users to keep track of when they took insulin
  • A dose calculator that allows people to more accurately determine how much insulin they need in a given situation
  • The ability to integrate CGM data into a pen

Here’s a closer look at these developments.

Concentrated Insulin

“We’ve seen tremendous improvements in using pens to dose concentrated insulin,” says Dr. Miller. “The pharmaceutical industry has gotten better at packaging those insulins in a safer way to be able to dose the amount of insulin that the patient needs.”

Patients who require higher doses of insulin than the traditional U-100 concentration because they have obesity or have insulin resistance only had U-500 insulin to turn to until recently. U-500 insulin also was previously only available as a vial — now it’s available as a pen, further facilitating dose calculation. “At 5 times the concentration of traditional insulin, it’s very dangerous in an inappropriate amount and without accurate dosing,” Miller says.

Newer pens on the market within the past few years contain varying concentrations of long-lasting (basal) insulin, such as a Tresiba FlexTouch pen with 3 mL of U-200 insulin degludec ($78.20 per pen retail, or $0.13 per unit); and a Toujeo Max SoloStar pen with 3 mL of U-300 insulin glargine ($347.01 per pen, or $0.58 per unit) — prices according to GoodRx. “As a result of the wider availability of some of the concentrated long-lasting insulins, like U-200, patients are able to absorb the insulin in a much more predictable way, and their basal insulin requirements are met more reasonably, accurately, and effectively,” says Miller.

Partial Units

The ability to give half-unit doses is another exciting development, according to Bzowyckyj. Those who are especially sensitive to insulin (such as children and older adults) and who use low amounts may be more prone to dosing errors.

 Half-unit functionality, such as that available in the Humalog Junior KwikPen ($82.18 retail per pen, or $0.27 per unit, according to GoodRx), makes it easier to deliver just the right amount of insulin.

Memory Functions

“For me, the most exciting new development is the dose memory functionality, which keeps track of the doses and times of insulin doses that a person self-administered recently,” Bzowyckyj says. “Oftentimes, it is easy for people to forget whether or not they administered their medications, especially with how hectic our lives can get. With traditional tablets and capsules, people can just check their pillbox to see if today’s space is empty, but unfortunately, that is not an option with insulin. The dose memory feature is a great way to prevent a person from double-dosing their insulin.”

One example is MiniMed’s InPen, which is compatible with Humalog and Novolog insulin cartridges. Prices vary by pharmacy, but the InPen for Humalog has a retail price of $973.97, and the Novolog version costs $1,037.10, according to GoodRx.

Smart caps, such as units from Bigfoot Unity, connect to disposable insulin pens and can record doses and integrate with CGMs. Versions for long-acting and rapid-acting insulin are available. Similarly, smart buttons are available that can attach to prefilled insulin pens. These connect to an app via Bluetooth to record dosing information.

Dose Calculators

Isaacs’s patients use the InPen, which she prefers to other pens. For instance, with the InPen, “there is a dosing calculator embedded in it, which makes calculations much easier,” she says. “The calculator makes it much easier to add the insulin needed for a given amount of carbohydrates and a certain glucose level. It may also subtract active insulin from a previous dose that is still working in the body through an advanced calculation.” That last function is one that Miller points out as being especially useful for avoiding dosing errors.

CGM Integration

Isaacs is excited about new developments that now allow dosing data from smart pens to be shared with continuous glucose monitors, such as a Freestyle Libre, Medtronic Guardian, and Dexcom G6. The CGMs use a sensor wire inserted under the skin and a small, portable transmitter to send data to a receiver or smart device 24 hours a day. They are typically used by people with type 1 diabetes and are especially useful for those who are at risk for hypoglycemia and either don’t recognize the signs or experience them overnight, though doctors are seeing more people with type 2 diabetes who are starting to use CGMs.

Despite these developments, some insulin users aren’t even aware that smart pens exist, according to Isaacs. Miller doesn’t see growing awareness necessarily translating into wider adoption of smart pens. Instead, he predicts that insulin users who are interested in technological improvement are more likely to move over to pump therapy rather than smart pens. “The patients I have who don’t want to go on a pump tell me that they want to stay on a [traditional] pen because the pens are simple. The pens are easier to use, and the patient doesn’t have to think about numbers and data. They just dial the dosage, they take it, and they are done.”

He also sees affordability as another barrier to wider adoption. “Outside of rebate programs and coupons, company certificates, and the like, I have not heard of robust insurance coverage from the managed-care and insurance companies to cover electronic pens over the cost of a traditional insulin pen.”

Weekly Injections Available Soon

The U.S. Food and Drug Administration has approved a new once-a-week insulin injection. The Awiqli FlexTouch pen, expected to be available in the United States in the second half of 2026, comes filled with 1.5 mL or 3 mL of concentrated U-700 insulin icodec-abae. It enables adults with type 2 diabetes to take injections once a week instead of daily. However, it’s important to take the dose on the same day each week and to take extra precautions because the insulin is so concentrated.

How to Pick an Insulin Pen With Your Doctor’s Help

So which option is best for you? Isaacs suggests asking your healthcare team the following questions to determine the best fit:

  • What are my insulin delivery options?
  • What options will insurance cover?
  • Would I benefit from having a dosing calculator to help calculate insulin doses?
  • Would I benefit from a pen that helps keep track of all insulin doses?
  • Would I benefit from a pen that knows when a previous insulin dose is still working in my system?

Insurance coverage will likely drive your choice, says Bzowyckyj. If you have multiple options, consider dexterity (some pens are spring-loaded while others require the ability to extend your thumb to administer the dose), whether you’ll need to administer partial doses, and whether you prefer a disposable pen or a reusable pen that has disposable cartridges, he says.

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Insulin, Medicines, & Other Diabetes Treatments. National Institute of Diabetes and Digestive and Kidney Diseases. March 2022.
  2. Hung A et al. The Ongoing Need to Address Cost-Related Nonadherence to Diabetes Medications. Diabetes Care. July 21, 2025.
  3. New Survey: Nearly 40 Percent of Insulin Users Polled Pay More Than $150 Per Month. American Diabetes Association. June 23, 2026.
  4. Smith T. Syringes vs. Pens vs. Smart Pens: Pros and Cons. Beyond Type 1. November 23, 2021.
  5. Payne M et al. Design of an Open Source Ultra Low Cost Insulin Pump. HardwareX. November 15, 2022.
  6. Marsh T. Insulin Costs Plummet: A Decade-Long High Comes to an End. GoodRx. January 15, 2025.
  7. Learning About Insulin Pens. Kaiser Permanente. March 2, 2026.
  8. Standards of Care in Diabetes—2026. American Diabetes Association. December 2025.
  9. Barber ML et al. Estimated Sustainable Cost-Based Prices for Diabetes Medicines. JAMA Network Open. March 27, 2024.
  10. Halverson R. Modern Insulin and Pens. The Diabetes Link.
  11. Falk E. Injections: Back to Basics. The Diabetes Link.
  12. How to Use an Insulin Pen. Memorial Sloan Kettering Cancer Center. March 20, 2024.
  13. Considerations for Blood Glucose Monitoring and Insulin Administration. Centers for Disease Control and Prevention. August 7, 2024.
  14. Insulin Pen Overview & FAQs. Danatech. June 8, 2023.
  15. Ambalavanan J et al. Diabetes Technology: A Primer for Clinicians. Cleveland Clinic Journal of Medicine. June 2024.
  16. Continuous Glucose Monitoring. National Institute of Diabetes and Digestive and Kidney Diseases. June 2023.
  17. Coming Soon! New Once-Weekly Insulin Pen. ConsumerMedSafety.org. June 1, 2026.
Sandy-Bassin-bio

Sandy Bassin, MD

Medical Reviewer

Sandy Bassin, MD, is an endocrinology fellow at Mount Sinai in New York City. She is passionate about incorporating lifestyle medicine and plant-based nutrition into endocrinology,...

Sheryl Huggins Salomon

Author

Sheryl Huggins Salomon has spent her career equipping people with information to help improve their well-being and prospects in life. She is a veteran journalist and editor who has...